These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30 related articles for article (PubMed ID: 15076230)
1. Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia. Hill MR; Clarke S; Rodgers K; Thornhill B; Peters JM; Gonzalez FJ; Gimble JM Infect Immun; 1999 Jul; 67(7):3488-93. PubMed ID: 10377130 [TBL] [Abstract][Full Text] [Related]
2. Activation of the peroxisome proliferator-activated receptor alpha protects against myocardial ischaemic injury and improves endothelial vasodilatation. Tabernero A; Schoonjans K; Jesel L; Carpusca I; Auwerx J; Andriantsitohaina R BMC Pharmacol; 2002 Apr; 2():10. PubMed ID: 11940253 [TBL] [Abstract][Full Text] [Related]
3. Fibrane the reduced derivative of fenofibrate. Kotheimer AE; Haq W; Balendiran GK Results Chem; 2020 Jan; 2():. PubMed ID: 32844085 [No Abstract] [Full Text] [Related]
4. DNA methylation as a marker of response in rheumatoid arthritis. Nair N; Wilson AG; Barton A Pharmacogenomics; 2017 Sep; 18(14):1323-1332. PubMed ID: 28836487 [TBL] [Abstract][Full Text] [Related]
5. An epigenome-wide association study of inflammatory response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network. Yusuf N; Hidalgo B; Irvin MR; Sha J; Zhi D; Tiwari HK; Absher D; Arnett DK; Aslibekyan SW Pharmacogenomics; 2017 Sep; 18(14):1333-1341. PubMed ID: 28835163 [TBL] [Abstract][Full Text] [Related]
6. Plasma folate, but not homocysteine, is associated with Apolipoprotein A1 levels in a non-fortified population. Söderström E; Eliasson M; Johnson O; Hallmans G; Weinehall L; Jansson JH; Hultdin J Lipids Health Dis; 2013 May; 12():74. PubMed ID: 23697869 [TBL] [Abstract][Full Text] [Related]
7. A review of time courses and predictors of lipid changes with fenofibric acid-statin combination. Filippatos TD Cardiovasc Drugs Ther; 2012 Jun; 26(3):245-55. PubMed ID: 22592524 [TBL] [Abstract][Full Text] [Related]
8. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice. Orasanu G; Ziouzenkova O; Devchand PR; Nehra V; Hamdy O; Horton ES; Plutzky J J Am Coll Cardiol; 2008 Sep; 52(10):869-81. PubMed ID: 18755353 [TBL] [Abstract][Full Text] [Related]
9. Should We Use PPAR Agonists to Reduce Cardiovascular Risk? Robinson JG PPAR Res; 2008; 2008():891425. PubMed ID: 18288293 [TBL] [Abstract][Full Text] [Related]
10. Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels. Dierkes J; Luley C; Westphal S Vasc Health Risk Manag; 2007; 3(1):99-108. PubMed ID: 17583180 [TBL] [Abstract][Full Text] [Related]
11. Update on PPAR agonists: the clinical significance of FIELD and PROACTIVE. Robinson JG Curr Atheroscler Rep; 2007 Jan; 9(1):64-71. PubMed ID: 17169249 [TBL] [Abstract][Full Text] [Related]